BC Innovations | Mar 3, 2011
Targets & Mechanisms

Targeting T cell metabolism

Researchers at the University of Michigan have shown that modulating ATP synthase activity can selectively kill alloreactive T cells and arrest graft-versus-host disease. 1 Lycera Corp. has licensed the findings, which may provide a new...
BC Innovations | Feb 24, 2011
Distillery Therapeutics

Indication: Transplantation

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Transplantation Graft-versus-host disease (GvHD) ATP synthase H+ transporting mitochondrial F1 complex O subunit (ATP5O; OSCP) Studies in mice suggest that inhibiting ATP5O...
Items per page:
1 - 2 of 2